NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01992172,Photocil (Topical) for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT01992172,,COMPLETED,Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of atopic dermatitis.,YES,Atopic Dermatitis,DRUG: Photocil for Atopic Dermatitis|OTHER: Placebo - Sunscreen (SPF 2),"Number of Pruritus Events in Last 30 Days, 30 days from baseline",,,"Applied Biology, Inc.",,ALL,"ADULT, OLDER_ADULT",NA,7,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",AB-DRUG-PHOTOCIL-AD-001,2013-08,2014-12,2014-12,2013-11-25,2015-12-11,2016-03-25,"Physicians Institute, Tucson, Arizona, 85719, United States",
